Issue of new ordinary shares

RNS Number : 7496I
The MedicX Fund Limited
20 June 2011
 



 

 

For immediate release

20 June 2011

 

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

 

Issue of new ordinary shares

 

 

MedicX Fund (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom, announces that on Friday 17 June 2011 it issued for cash 500,000 new ordinary shares of no par value in the Company (the "New Shares").  The issue price per New Share (before expenses) is 78.25 pence.

 

The net proceeds will be used in further pursuing the investment objectives of the Company.

 

The New Shares will be admitted to the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange's main market for listed securities pursuant to the block listing application announced by the Company on 26 June 2008.

 

Following this issue, the Company has 190,813,101 ordinary shares in issue.

 

 

End

 

 

For further information please contact:

 

MedicX Group:                                                               +44 (0) 1483 869 500

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

 

Collins Stewart Europe Limited:                                       +44 (0) 20 7523 8000

Andrew Zychowski/Helen Goldsmith

 

Buchanan Communications:                                             +44 (0) 20 7466 5000

Charles Ryland/Suzanne Brooks

  

MedicX Fund:                                                                 +44 (0) 1481 723 450

David Staples, Chairman

 

Information on MedicX Fund Limited

 

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 59 properties.

 

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 31 people operating across the UK.  

 

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEZMGZVFGMGMZM
UK 100

Latest directors dealings